Life Sciences Law & Industry Report connects the dots among the many disciplines that make up the burgeoning life sciences industry, with biweekly updates on current regulatory, legislative,...
By Jeannie Baumann
Jan. 28 — The White House's “moonshot” initiative to double the rate of progress on cancer treatments and prevention will be led by a high-level, federal task force, according to a Jan. 28 presidential memorandum.
In establishing the White House Cancer Moonshot Task Force, President Barack Obama took the next major step in moving forward an initiative he first unveiled during his final State of the Union address on Jan. 13 (10 LSLR 02, 1/22/16). Vice President Joe Biden, , who will serve as chairman of the task force, said in a separate announcement that the first meeting has been scheduled for Feb. 1.
“This will be the first time this kind of group has met as a team, charged with this kind of goal,” Biden said on the online publishing portal Medium.com. And we’re going to continue to meet in the months to come—and lay the groundwork for the next Administration.”
In the memorandum, Obama said cancer research is on the cusp of major breakthroughs. “It is of critical national importance that we accelerate progress towards prevention, treatment, and a cure—to double the rate of progress in the fight against cancer—and put ourselves on a path to achieve in just [five] years research and treatment gains that otherwise might take a decade or more,” the memorandum said.
The members of the task force will include the heads, or their proxies, of at least 13 federal agencies, ranging from the National Institutes of Health and the Food and Drug Administration to representatives from the departments of Commerce and Energy. Although part of the NIH, the National Cancer Institute will have its own separate membership. No private sector representatives will serve on the task force, Bloomberg Government confirmed Jan. 28.
According to the memorandum, the task force will deliver a set of findings and recommendations to:
The report is due Dec. 31.
Funding and administrative support for the task force will come from the NIH's budget, and Biden is expected to designate an executive director to coordinate the group's work, the memorandum said.
Responding to Obama's announcement, Sen. Lamar Alexander (R-Tenn.) said in a Jan. 28 statement, “We are working in the Senate health committee to send to the president's desk bipartisan legislation that would safely bring lifesaving drugs and medical devices to patients more quickly.”
As chairman of the Senate Health, Education, Labor and Pensions Committee, Alexander has been working with the panel's top Democrat, Sen. Patty Murray (D-Wash.), over the past year on a Senate companion measure to the House-passed 21st Century Cures bill (H.R. 6). Alexander said in mid-January that the HELP Committee would hold a series of three markup sessions on this effort, with the first one scheduled for Feb. 9 (10 LSLR 02, 1/22/16)
To contact the reporter on this story: Jeannie Baumann in Washington at email@example.com
To contact the editor responsible for this story: Randy Kubetin at firstname.lastname@example.org
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to email@example.com.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to firstname.lastname@example.org.
Put me on standing order
Notify me when new releases are available (no standing order will be created)